Danhong injection alleviates cerebral ischemia-reperfusion injury by inhibiting autophagy through miRNA-132-3p/ATG12 signal axis

被引:18
|
作者
Zhang, Hongrui [1 ]
Wang, Xinyi [1 ]
Chen, Weiwei [1 ]
Yang, Yixuan [1 ]
Wang, Yu [1 ]
Wan, Haitong [1 ]
Zhu, Zhenhong [1 ]
机构
[1] Zhejiang Chinese Med Univ, Coll Life Sci, 548 Binwen Rd, Hangzhou 310053, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Danhong injection; Cerebral ischemia-reperfusion; miR-132-3p; Autophagy; ATG12; BRAIN; MICRORNA; RAT; NEUROPROTECTION; METABOLISM; STROKE; MODEL;
D O I
10.1016/j.jep.2022.115724
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Danhong injection (DHI) is a renowned traditional Chinese medicine often used clinically to treat cardiovascular and cerebrovascular diseases. Studies have shown that DHI can significantly alter microRNA (miRNA) expression in the brain tissue. Therefore, exploring specific miRNAs' regulatory mechanisms during treatment with DHI is essential. Aim of the study: To investigate DHI's regulatory mechanism on cerebral autophagy in rats with cerebral ischemia-reperfusion injury (CIRI). Material and methods: Rats were randomly divided into the sham, middle cerebral artery occlusion (MCAO) model, and DHI-treatment groups. The extent of brain damage was evaluated using triphenyl tetrazolium chloride and hematoxylin-eosin staining. Hippocampal cell autophagy was observed using transmission electron microscopy. Autophagy-related proteins were analyzed using western blotting. Differentially expressed miRNAs were screened using high-throughput and real-time quantitative reverse transcription PCR. The relationship between miR-132-3p and ATG12 was confirmed using a dual-luciferase assay. The miR-132-3p mimics and inhibitors were transfected into PC12 cells subjected to oxygen-glucose deprivation (OGD) in vitro and MCAO model rats in vivo. Results: DHI significantly altered the miRNA expression profile in rat brain tissues. The pathological changes in the brain tissues were improved, and the autophagic hippocampal cell vehicles were significantly reduced after DHI treatment. miRNA-132-3p, one of the miRNAs with a significantly different expression, was screened. Kyoto Encyclopedia of Genes and Genomes signal pathway analysis showed that its target genes were closely related to autophagy. Western blotting revealed that the p-PI3K, p-AKT, and mTOR expression increased significantly; AMPK, ULK1, ATG12, ATG16L1, and LC3II/I were downregulated in the DHI group. Dual-luciferase reporter gene experiments showed that miRNA-132-3p could target the ATG12 3'-UTR region directly. In vitro, miRNA-132-3p had a protective effect on OGD/R-induced oxidative stress injury in PC12 cells, improving cell viability, and affecting the expression of autophagy pathway-related proteins. In vivo transfection experiments showed that miR-132-3p could regulate ATG12 expression in CIRI rats' lateral brain tissue, affecting the autophagy signaling pathway. miR-132-3p overexpression reduces CIRI-induced autophagy and protects neurons. Conclusion: This study showed that DHI inhibits neuronal autophagy after cerebral ischemia-reperfusion. This may have resulted from miR-132-3p targeting ATG12 and regulating the autophagy signaling pathway protein expression.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] MicroRNA-32-3p facilitates cerebral ischemia/reperfusion injury through inhibiting Cab39/AMPK
    Tao, Hongmiao
    Dong, Lihua
    Shan, Xiaoyun
    Li, Lin
    Chen, Haohao
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 121
  • [42] LncRNA SNHG15 regulates autophagy and prevents cerebral ischaemia-reperfusion injury through mediating miR-153-3p/ATG5 axis
    Yu, Yunhu
    Cai, Yunpeng
    Zhou, Hang
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (05)
  • [43] Gomisin N attenuated cerebral ischemia-reperfusion injury through inhibition of autophagy by activating the PI3K/AKT/mTOR pathway
    Li, Ruoqi
    Zheng, Yingyi
    Zhang, Jiaxue
    Zhou, Yuan
    Fan, Xiang
    PHYTOMEDICINE, 2023, 110
  • [44] Gastrodin Alleviates Cerebral Ischaemia/Reperfusion Injury by Inhibiting Pyroptosis by Regulating the lncRNA NEAT1/miR-22-3p Axis
    Heng-Sheng Zhang
    Bo Ouyang
    Xiong-Ying Ji
    Mei-Fang Liu
    Neurochemical Research, 2021, 46 : 1747 - 1758
  • [45] Gastrodin Alleviates Cerebral Ischaemia/Reperfusion Injury by Inhibiting Pyroptosis by Regulating the lncRNA NEAT1/miR-22-3p Axis
    Zhang, Heng-Sheng
    Ouyang, Bo
    Ji, Xiong-Ying
    Liu, Mei-Fang
    NEUROCHEMICAL RESEARCH, 2021, 46 (07) : 1747 - 1758
  • [46] Knockdown of lncRNA TTTY15 alleviates myocardial ischemia-reperfusion injury through the miR-374a-5p/FOXO1 axis
    Chen, Yong-Quan
    Yang, Xin
    Xu, Wei
    Yan, Yi
    Chen, Xi-Ming
    Huang, Zhao-Qi
    IUBMB LIFE, 2021, 73 (01) : 273 - 285
  • [47] Orexin-A protects against cerebral ischemia-reperfusion injury by inhibiting excessive autophagy through OX1R-mediated MAPK/ERK/mTOR pathway
    Xu, Dandan
    Kong, Tingting
    Zhang, Shengnan
    Cheng, Baohua
    Chen, Jing
    Wang, Chunmei
    CELLULAR SIGNALLING, 2021, 79
  • [48] 15-Deoxy-Δ12,14-prostaglandin J2 alleviates hepatic ischemia-reperfusion injury in mice via inducing antioxidant response and inhibiting apoptosis and autophagy
    Kan Chen
    Jing-jing Li
    Sai-nan Li
    Jiao Feng
    Tong Liu
    Fan Wang
    Wei-qi Dai
    Yu-jing Xia
    Jie Lu
    Ying-qun Zhou
    Chuan-yong Guo
    Acta Pharmacologica Sinica, 2017, 38 : 672 - 687
  • [49] Aloe-emodin alleviates cerebral ischemia-reperfusion injury by regulating microglial polarization and pyroptosis through inhibition of NLRP3 inflammasome activation
    Li, Xun
    Yao, Minghe
    Li, Lingling
    Ma, Huifen
    Sun, Yiran
    Lu, Xiangpeng
    Jing, Weipeng
    Nie, Shanshan
    PHYTOMEDICINE, 2024, 129
  • [50] 15-Deoxy-Δ12,14-prostaglandin J2 alleviates hepatic ischemia-reperfusion injury in mice via inducing antioxidant response and inhibiting apoptosis and autophagy
    Chen, Kan
    Li, Jing-jing
    Li, Sai-nan
    Feng, Jiao
    Liu, Tong
    Wang, Fan
    Dai, Wei-qi
    Xia, Yu-jing
    Lu, Jie
    Zhou, Ying-qun
    Guo, Chuan-yong
    ACTA PHARMACOLOGICA SINICA, 2017, 38 (05) : 672 - 687